Paul Adedoyin, MD
Radiation Oncology · Huntington, WVNPI 1265888762
Payments from drug & device makers
What this record shows
Palette Life Sciences, Inc. accounts for 69.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $2,023 and has fallen 89.5% since, to $211 in 2025.
Across 25 payments — averaging $106.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$2K
- Reflexion Medical, Inc.$150
- Elekta, Inc.$127
- Boston Scientific$117
- Philips North America LLC$110
- Novartis$85
- plus $239 from 9 others
What the payments were for
- Travel & lodging$1,50156%
- Food & beverage$1,17344%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 4 | $1,846 |
| Reflexion Medical, Inc. | 2 | $150 |
| Elekta, Inc. | 2 | $127 |
| Boston Scientific | 3 | $117 |
| Philips North America LLC | 1 | $110 |
| Novartis | 4 | $85 |
| MIM Software Inc. | 1 | $58 |
| Siemens Medical Solutions USA, Inc. | 1 | $27 |
| Myovant Sciences Inc. | 1 | $25 |
| Sanofi | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Sobi, Inc | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$118
- (4108) PD Ventures$110
- ELEKTA UNITY$109
- Mosaiq$109
- Monaco$109
- PROKNOW DS$109
- LEKSELL GAMMA KNIFE ICON$109
How this compares
$2,673 in reported general payments places this provider in the 85th percentile of 29 radiation oncology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 22 | $55,461 |
| Betamethasone Dipropionate | 26 | $1,030 |
| Tamsulosin Hcl | 50 | $621 |
| Oxybutynin Chloride | 14 | $93 |
| SsdSilver Sulfadiazine | 16 | $50 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Huntington
- John VarlottoHuntington$120K
- Sanjeev SharmaHuntington$1K
- Grace DixonHuntington$145
- Mary ContiHuntington$108
- Sophia Edwards-BennettHuntington$47
- Gregory MerrickWheeling$21K
- David ShimmBeckley$5K
- Benjamin YanMorgantown$2K
- Michael GallowayElkins$1K
- Jondavid PollockWheeling$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.